IP Library Granted Patent US 7,728,030
Granted Patent B2
US 7,728,030 · App. 12/005,066 · Granted Jun 1, 2010

Chemical compounds 572

Assignees: AstraZeneca AB; Bayer Schering Pharma Aktiengesellschaft
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,728,030
App. No.
12/005,066
Granted
Jun 1, 2010
Kind
B2
Abstract

Compounds of formula (I): The present invention relates to novel indazolyl ester or amide derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments.

Claims (4)

1. 2,2,2-Trifluoro-N-[(1R,2S)-1-[1-(4-fluorophenyl) indazol-5-yl]oxy-1-(3-methoxyphenyl)propan-2-yl]acetamide, or a pharmaceutically acceptable salt thereof.

2. A pharmaceutical composition comprising a compound or a pharmaceutically acceptable salt thereof as claimed in claim 1 , and a pharmaceutically acceptable adjuvant, diluent or carrier.

3. A method of treating asthma, which comprises administering to a mammal in need of such treatment an effective amount of a compound or a pharmaceutically acceptable salt thereof as claimed in claim 1 .

4. A method of treating COPD, which comprises administering to a mammal in need of such treatment an effective amount of a compound or a pharmaceutically acceptable salt thereof as claimed in claim 1 .

Assignments (3)
CHANGE OF NAME Recorded Sep 30, 2013
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 031315/0607 →
CORRECTIVE ASSIGNMENT TO CORRECT THE OMISSION OF THE SECOND ASSIGNEE, WHICH IS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, MULLERSTRASSE 178, D-13353, BERLIN, GERMANY PREVIOUSLY RECORDED ON REEL 020944 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE OMISSION OF THE SECOND ASSIGNEE AS SHOWN ON THE ATTACHED ASSIGNMENT. Recorded Feb 3, 2010
From: DAHMEN, JAN; ERIKSSON, ANDERS; GABOS, BALINT; HANSSON, THOMAS; HENRIKSSON, KRISTER; LEPISTO, MATTI; MUNCK AF ROSENSCHOLD, MAGNUS; NILSSON, STINABRITT; HEMMERLING, MARTIN; IVANOVA, SVETLANA; EDMAN, KARL; BERGER, MARKUS; REHWINKEL, HARTMUT; MCKERRECHER, DARREN; TAFLIN, CAMILLA
To: ASTRAZENECA AB; BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023893/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2008
From: DAHMEN, JAN; ERIKSSON, ANDERS; GABOS, BALINT; HANSSON, THOMAS; HENRIKSSON, KRISTER; LEPISTO, MATTI; MUNCK AF ROSENSCHOLD, MAGNUS; NILSSON, STINABRITT; HEMMERLING, MARTIN; IVANOVA, SVETLANA; EDMAN, KARL; BERGER, MARKUS; REHWINKEL, HARTMUT; MCKERRECHER, DARREN; TAFLIN, CAMILLA
To: ASTRAZENECA AB
Reel/Frame 020944/0199 →
Continuity (4)
Provisional Application 6097852600 · Oct 9, 2007
Provisional Application 6094174500 · Jun 4, 2007
Provisional Application 6087118400 · Dec 21, 2006
Related Publication 20080214641A1 · Sep 4, 2008